Clinical Research Directory
Browse clinical research sites, groups, and studies.
Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University
Summary
The purpose of this multicenter randomized clinical trial is to evaluate the myopia control effect of orthokeratology and 0.01% atropine sequential treatment in children and adolescents, as compared to continuous treatment with orthokeratology.
Official title: Myopia Control Effect of Orthokeratology and 0.01% Atropine Sequential Treatment in Children and Adolescents: A Multicenter Randomized Controlled Trial
Key Details
Gender
All
Age Range
8 Years - 15 Years
Study Type
INTERVENTIONAL
Enrollment
194
Start Date
2024-09-21
Completion Date
2027-03-31
Last Updated
2025-02-26
Healthy Volunteers
No
Conditions
Interventions
Ortho-k lenses
Ortho-k lenses will be administered nightly.
0.01% Atropine
0.01% Atropine will be administrated twice a day with an interval of about 12 hours. Drop into the conjunctival sac and immediately compress the lacrimal sac of the inner canthus for 2-3 minutes.
Locations (1)
Zhongshan Ophthalmic Center Sun Yat-Sen University
Guangzhou, Guangdong, China